AMOEBA (EPA:ALMIB) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 06/21/2024 at 13:36, 5 months ago

Edison issues report on Amoéba (ALMIB)
Edison Investment Research Limited issues report on Amoéba (ALMIB) available for download. Not a solicitation to buy or sell securities

AMOEBA Edison Investment Research Limited Financial Analysis Report ALMIB
BRIEF

published on 06/10/2024 at 17:50, 5 months 10 days ago

AMOÉBA Confirms Development Potential in Cosmetics Sector

AMOEBA Clinical Study Cosmetics Skincare INCI List
REGULATED PRESS RELEASE

published on 06/10/2024 at 17:45, 5 months 10 days ago

CONFIRMATION OF THE DEVELOPMENT POTENTIAL OF AMOEBA IN COSMETICS
Amoéba's clinical study confirms the development potential of its cosmetic ingredient for skincare products. Management to present strategy at annual conference in Paris

AMOEBA Clinical Study Cosmetics Paris Conference Skincare Products
BRIEF

published on 05/23/2024 at 18:05, 5 months 28 days ago

AMOEBA: Ordinary and Extraordinary General Meeting Scheduled for June 27, 2024

AMOEBA Shareholders General Meeting Electronic Voting June 2024
REGULATED PRESS RELEASE

published on 05/23/2024 at 18:00, 5 months 28 days ago

AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
Amoéba announces Ordinary and Extraordinary General Meeting on June 27, 2024, in Chassieu. Shareholders can access preliminary documents online. Electronic voting available

AMOEBA Shareholders General Meeting Electronic Voting Preliminary Documents
BRIEF

published on 05/06/2024 at 17:50, 6 months 14 days ago

AMOEBA: Declaration of the total number of voting rights and the number of shares making up the capital as of April 30, 2024

AMOEBA Voting Rights Capital Financial Markets Authority April 30, 2024
BRIEF

published on 05/02/2024 at 18:05, 6 months 18 days ago

Amoéba Announces Renewal of Board of Directors to Propel Strategic Growth

AMOEBA Board Of Directors Strategic Growth Biocontrol Cosmetics Industry
REGULATED PRESS RELEASE

published on 05/02/2024 at 18:00, 6 months 18 days ago

Amoéba's Board of Directors renewed to support the company's new strategic ambitions.
Amoéba's Board of Directors renewed to support the company's new strategic ambitions by appointing new figures specialized in core activities

AMOEBA Board Of Directors Appointments Biocontrol Strategic Ambitions
BRIEF

published on 04/29/2024 at 17:50, 6 months 21 days ago

AMOEBA Announces Filing of Universal Registration Document for 2023

AMOEBA Corporate Governance Universal Registration Document 2023 Financial Report AMF Filing
REGULATED PRESS RELEASE

published on 04/29/2024 at 17:45, 6 months 21 days ago

AMOEBA ANNOUNCES AVAILABILITY OF UNIVERSAL REGISTRATION DOCUMENT 2023
Amoéba announces availability of Universal Registration Document 2023 covering financial year ending on Dec 31, 2023, including annual financial report and corporate governance report

AMOEBA Financial Year Corporate Governance Annual Financial Report Universal Registration Document 2023

Accesswire

Published on 11/21/2024 at 13:30, 36 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 51 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 59 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 6 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE